Work

Abstract B001: Effective targeting p53 mutant pancreatic cancer by novel drug-combination strategy leveraging their DNA damage liabilities

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.pancreatic25-b001

Authors: Andrei Bakin, Mohammed Alruwaili, Ashley Guo, Thomas Melendy, Barbara Foster, Christos Fountzilas

Institutions: Roswell Park Comprehensive Cancer Center, University at Buffalo, State University of New York

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414585595

Cites:

Cited by:

Related to: